SecBot SecBot

PAHC

PHIBRO ANIMAL HEALTH CORP
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001069899 Biotech & Drug Discovery
$35.02 −0.95 (−2.64%)
Nov 16 4:00 PM ET · prev $35.97
Market cap
$1.4B
Small cap
Median target
$49.00
+40% · range $37.00–55.00
1 year
−22.3%
from $45.06 · Nov 17
30 days
−11.0%
from $39.34
52-week range
$28.52–59.58
−41% from high · low Jun 2
Avg volume 20D
205.2K
shares / day
Short interest
1.02M
≈2.5% of shares · −1.3%
Days to cover
6.4
at average volume
Insider net
−$5.0M
1 buyer · 1 seller · since Mar 30
New fund stakes
1
Q3 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $317.7K at an average $31.77. 1 insider sold $5.3M. Price is 10% above their cost.

  • InstitutionsBULLISH

    Q3 2026: 23 added (1 new), 9 trimmed or exited. Largest new: Boston Partners $10.9M.

  • Short sellersSTEADY

    Short interest −1.3% to 1.02M shares. 6.4 days to cover, ≈2.5% of shares.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q3 2026
1
new positions
0
exits
$10.9M
in new stakes
FundMoveSharesValue
Boston PartnersNEW304,347$10.9M
Invesco Ltd.TRIM149,730$5.4M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD94,847$3.5M
MARSHALL WACE, LLPDOUBLED93,898$3.4M
Quantinno Capital Management LPADD35,515$1.3M
Neuberger Berman Group LLCADD31,825$1.1M
Quadrature Capital LtdDOUBLED17,804$636.3K
VANGUARD ASSET MANAGEMENT, LtdADD17,141$612.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action May 2026
12-month targets · 3 analysts

Price is below the lowest target. Median implies +40%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
May 14, 2026Citigroup
MAINTAIN
MAINTAINNeutral
Apr 15, 2026Citigroup
INITIATE
INITIATENeutral
Nov 7, 2025JP Morgan
MAINTAIN
MAINTAINOverweight
Aug 29, 2025B of A Securities
MAINTAIN
MAINTAINUnderperform
Jul 7, 2025JP Morgan
UPGRADE
UPGRADEOverweight
Jun 25, 2025Morgan Stanley
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$317.7K
bought · 1 insider
$5.3M
sold · 1 insider
+10.2%
vs their $31.77 cost
DateInsiderTypeValue
Aug 6, 2026
David Glenn
Chief Financial Officer
Aug 6, 2026
AWARD3,482 sh
Aug 6, 2026
Miller Larry Lee
Chief Operating Officer
Aug 6, 2026
AWARD3,726 sh
Aug 6, 2026
Bendheim Daniel M
President and CEO
Aug 6, 2026
AWARD11,699 sh
Aug 6, 2026
BENDHEIM JACK
Executive Chairman
Aug 6, 2026
AWARD12,103 sh
Aug 6, 2026
Miller Larry Lee
Chief Operating Officer
Aug 6, 2026
AWARD3,522 sh
Aug 6, 2026
Escudero Lisa Ann
See Remarks
Aug 6, 2026
AWARD1,547 sh
Aug 6, 2026
Weinstein Judith
See Remarks
Aug 6, 2026
AWARD2,478 sh
Aug 6, 2026
David Glenn
Chief Financial Officer
Aug 6, 2026
AWARD3,334 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$0.87$0.84–$0.89+2.0%$397.0M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

13 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
1,019,391
shares short
-1.3%
vs prior settlement
6.4
days to cover
≈2.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 4, 2026 SEC
Phibro Animal Health reported Q1 FY2027 net sales of $386.8M (+6% YoY) and GAAP diluted EPS of $0.72 (+11% YoY)…
8-K · Impact 4/10
Nov 4, 2026 Earnings result
PAHC Q1 2027 Earnings: EPS $0.79 (-2.6% vs est)
Nov 3, 2026 SEC
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B…
8-K · Impact 2/10
Oct 19, 2026 SEC
Millennium Management LLC filed an amended Schedule 13G disclosing a passive 3.9% stake in Phibro Animal Health Corp…
SC 13G/A · Impact 5/10
Sep 30, 2026 Inst.
Boston Partners · NEW
304,347 shares ($10.9M)
Sep 30, 2026 Inst.
Invesco Ltd. · TRIM
149,730 shares ($5.4M)
Aug 6, 2026 Insider
David Glenn was granted 3,482 shares
Chief Financial Officer
Aug 6, 2026 Insider
Miller Larry Lee was granted 3,726 shares
Chief Operating Officer
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

9 filings · 1 bullish · 2 bearish · 6 neutral
All PAHC filing & press-release reports (9)